Marker Therapeutics, Inc. (MRKR)
2.00
-0.07
(-3.38%)
USD |
NASDAQ |
Jan 09, 16:00
2.05
+0.05
(+2.50%)
After-Hours: 20:00
Marker Therapeutics EPS Diluted (Quarterly): -0.1193 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| Viridian Therapeutics, Inc. | -0.423 |
| Neurocrine Biosciences, Inc. | 2.044 |
| Kiniksa Pharmaceuticals International Plc | 0.2303 |
| AIM ImmunoTech, Inc. | -1.567 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.999M |
| Revenue (Quarterly) | 1.233M |
| Total Expenses (Quarterly) | 3.232M |
| Enterprise Value | 14.40M |
| Profit Margin (Quarterly) | -162.1% |
| Earnings Yield | -61.45% |
| Normalized Earnings Yield | -61.45 |